No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
No Data
Oncternal Therapeutics Announces Intent to Voluntarily Delist From Nasdaq and Deregister With the SEC
12 Health Care Stocks Moving In Monday's Pre-Market Session
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
Top Premarket Decliners
On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing